Research & Analysis
Antibiotics should be used only to treat bacterial infections, and should be prescribed only in doses and fordurations appropriate for the patient and infection being treated. Yet the Centers for Disease Control andPrevention (CDC) estimates that up to 50 percent of all antibiotics prescribed in the U.S. are unnecessaryor inappropriate, with many of them prescribed in inpatient settings. Read More
The U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) today passed the Promise for Antibiotics and Therapeutics for Health (PATH) Act, a bipartisan bill introduced by Sens. Orrin Hatch (R-UT) and Michael Bennet (D-CO) that would advance the development of new antibiotics for seriously ill patients with unmet medical needs. Read More
Developing new antibiotics for seriously ill patients with unmet medical needs is essential in the fight against superbugs. The Generating Antibiotic Incentives Now (GAIN) Act, which grants an additional five years of exclusivity (without generic competition) to new antibiotics that treat serious or life-threatening infections, was signed into law in July 2012 to help address the financial... Read More
Support our Work
Invest with Pew to combat antibiotic resistance.